FIGURE 1.
Flow diagram representing search and selection of studies comparing 30 versus 40 mg of afatinib treatment in patients with EGFR-mutant NSCLC.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.